- » Focus and Scope
- » Section Policies
- » Peer Review Process
- » Publication Frequency
- » Open Access Policy
- » Archiving
Focus and Scope
Rare Tumors is a new, peer-reviewed, online-only, Open Access scientific journal publishing original papers, brief reports, and reviews on any aspect of rare tumors.
Rare Tumors is the premier peer-reviewed international medical journal devoted entirely to the study, diagnosis, and treatment of rare cancers. The journal cover the diagnosis, classification, and treatment of rare tumors and hematological malignancies for physicians and medical scientists interested in uncommon neoplasms. The primary intent of the journal will be to publish clinically relevant information that will directly improve the care of patients with rare cancers. Basic science studies of interest to those treating rare malignancies will also be considered for publication when relevant. A special section of the journal is dedicated to Case Reports: we would like to invite clinicians and researchers to send us their reports.
Section Policies
Articles
 Open Submissions |
Indexed |
Peer Reviewed |
Letters to the Editor
| Open Submissions |
Indexed |
 Peer Reviewed |
Reviews
| Open Submissions |
Indexed |
Peer Reviewed |
Case Reports
| Open Submissions |
Indexed |
Peer Reviewed |
Brief Reports
| Open Submissions |
Indexed |
Peer Reviewed |
Peer Review Process
All of our journals follows the WAME Recommendations on Publication Ethics Policies for Medical Journals about peer-review. The Editorial Board of each journal will immediately screen all articles submitted for publication in that journal. Those articles which fail to reach the scientific standards of the journal may be declined without further review. Those articles which satisfy the requirements of the Editorial Board will be sent to a maximum of three referees. These are experts in the field who have agreed to provide a rapid assessment of the article. Every effort will be made to provide an editorial decision as to acceptance for publication within 4-5 weeks of submission. Referees may request a revision of the article to be made. In this case, it is generally understood that only one revised version can be considered for a further appraisal under the peer-review system. The Editorial Board of each journal is responsible for the final selection of referees to conduct the peer-review process for that journal. The names of referees will not be made available to authors. However, referees will be informed as to the identity of the authors whose articles are subject to review. All members of the Editorial Board and referees are asked to declare any competing interests they may have in reviewing a manuscript. If on receiving the editorial decision concerning their manuscript authors are not satisfied they are invited to appeal to the Editorial Office. In cases in which this is considered appropriate a second opinion on the manuscript will be requested.
Publication Frequency
All papers are published as soon as they have been accepted, by adding them to the "current" volume's Table of Contents.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Archiving
This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...
Rare Tumors [ISSN 2036-3605, eISSN 2036-3613] is an Open Access, peer-reviewed journal published by PAGEPress, Pavia, Italy. All credits and honors to PKP for their OJS.